Canada Health And Medical Insurance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The canada health and medical insurance market size in terms of premium value is expected to grow from USD 73.60 billion in 2025 to USD 81.20 billion in 2026 and is forecast to reach USD 132.73 billion by 2031 at 10.33% CAGR over 2026-2031. This report is Segmented by Insurance Product Type (Private Medical Insurance, Public/Social Security Schemes), Term of Coverage (Short-Term, Long-Term), Distribution Channel (Brokers/Agents, Banks (Bancassurance), and More), End-User Segment (Individuals, Smes, Large Corporates), and Geography (Ontario, Quebec, and More). The Market Forecasts are Provided in Terms of Value (USD).

Canada Health and Medical Insurance Market Trends and Insights

Employer-Sponsored Group Benefits Dominance

Employer-sponsored benefits anchor access to non-hospital services and top-up coverage, which supports steady enrollment and renewals across the Canadian health and medical insurance market. Ontario’s 2025 to 2026 plan sustains system capacity with multi-billion allocations to hospitals, physician services, and home and community care, reinforcing the complementary role of private plans for prescription drugs outside hospitals, dental, vision, and paramedical services . Large distribution partners are using analytics to tailor plan designs and engagement for multigenerational workforces, which improves alignment with chronic disease risks and disability management goals. Carriers that blend digital channels with in-person support are deepening member relationships and reducing administrative friction through connected care and modern claims engines. These conditions help maintain employer coverage as the dominant channel in 2025 and preserve its strategic role in product innovation within the Canadian health and medical insurance market.

Virtual Care Integration Embedded in Group Plans

Virtual care is a permanent feature of group plans, with platforms providing fast access, clinical navigation, and pharmacy services that reduce unnecessary in-person visits and support continuity of care. Capabilities now include e-claims, expanded chronic care pathways, and programs that connect primary and specialty teams along a single member journey, which improves satisfaction and adherence. Pharmacy innovations and digital prescription tools enable synchronized refills and automated workflows, lowering administrative delays and supporting timely therapy starts. These tools shape expectations for omnichannel access across chat, video, and in-person consultations, which influences plan communications and benefit usage across the Canadian health and medical insurance market. Insurers are adopting AI-enabled triage and claims automation that shorten cycle times and standardize experiences across digital service layers.

Specialty Drug Inflation Raising Loss Ratios in Private Plans

Specialty drug costs are the largest single driver of private plan trend, with biologic disease modifiers across inflammatory and ophthalmology conditions absorbing a rising share of spend through 2024 and 2025. Weight-management therapies accelerated in 2024 after new launches, which increased exposure for sponsors that operate open formularies and broad coverage criteria. Biosimilar-first strategies and step therapy are gaining ground as plan sponsors seek to offset inflationary pressure while maintaining access, and public biosimilar policies provide reference points for private alignment. Prior authorization measures for select therapies are being refined to ensure clinical appropriateness and adherence to label, which moderates off-label use and non-essential demand. This environment is shaping benefit design changes across the Canadian health and medical insurance market to protect loss ratios and coverage sustainability for employers and individuals.

Other drivers and restraints analyzed in the detailed report include:

• Biosimilar Switching Momentum Shaping Private Formularies
• Quebec RAMQ Private Plan Mandate Sustaining Coverage Penetration
• Distribution Channel Licensing (MGA) Raising Compliance Costs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Public and social security schemes commanded 76.82% share in 2025, and this segment of the Canada health and medical insurance market size is projected to expand at an 8.24% CAGR through 2031 as provinces reinforce core access under the medicare framework. The Canada Health Act sets requirements for publicly insured hospital and physician services, and provinces extend these programs with targeted benefits for drugs and dental care that vary by income and eligibility rules . Provincial per-capita health spending differs by geography and age profile, with higher costs in territories and Atlantic regions that reflect service delivery challenges and older populations. Quebec’s hybrid model mandates universal drug coverage through RAMQ or qualifying private plans, which ensures both continuity and comparability of protection across residents. British Columbia and Ontario are adding operating budgets and pharmacare investments, which improve baseline capacity and reduce out-of-pocket exposure for covered categories.

Private medical insurance accounts for the remaining share and fills coverage gaps for prescriptions outside hospitals, dental, vision, paramedical services, enhanced hospital accommodations, and medical transportation above provincial schedules. Group coverage dominates private distribution and remains attractive through employer cost-sharing and negotiated service models, while individual coverage supports retirees, the self-employed, and those not eligible for workplace plans. Public drug policies, especially biosimilar switching, influence private formulary decisions as carriers seek to keep alignment with provincial plans and reduce adjudication friction. As pharmacare pilots mature, private plans are emphasizing navigation, mental health, and specialty pharmacy management to maintain clear value propositions in the Canada health and medical insurance industry.

Long-term coverage at 12 months or more held 94.63% of the premium share in 2025, and this segment of the Canadian health and medical insurance market is expected to advance at a 3.08% CAGR through 2031 due to annual renewals and stable employer participation. Employers calibrate eligibility, waiting periods, and cost-sharing to meet workforce needs, which sustains membership over time and aligns with annual review cycles. Group pooling and multi-year procurement reduce volatility from catastrophic claims compared with standalone individual underwriting, which supports predictable renewal outcomes. Analytics and modern communications are improving plan navigation and benefits literacy among employees, which raises perceived value and utilization. These features keep long-term structures as the default for employer coverage across the Canadian health and medical insurance market.

Short-term coverage under 12 months captures a small residual share and addresses episodic needs such as travel health or temporary medical coverage for visitors and students, while most Canadians rely on long-term plans for ongoing protection. Carriers are modernizing underwriting and onboarding with AI to speed decisions for eligible applications, which strengthens the case for durable contracts and lowers acquisition costs. Multi-year community health partnerships, such as diabetes prevention clinics, connect insurance with prevention and remission programs that enhance long-term member retention. As provinces invest in primary and acute care, the short-term segment will remain focused on travel and specialized events rather than replacing long-term structures in the Canadian health and medical insurance industry.

Complete Report Scope:

• By Insurance Product Type
  • Private Medical Insurance (PMI)
    • Individual Policy Coverage
    • Group Policy Coverage
  • Public / Social Security Schemes
• By Term of Coverage
  • Short-term (Less Than 12 months)
  • Long-term (Greater Than Equal to 12 months)
• By Distribution Channel
  • Brokers / Agents
  • Banks (Bancassurance)
  • Direct-to-Consumer (Online / Phone)
  • Employer-Sponsored (Companies)
  • Other Channels (Affinity, Associations)
• By End-user Segment
  • Individuals
  • SMEs
  • Large Corporates
• By Geography
  • Ontario
  • Quebec
  • British Columbia
  • Alberta
  • Rest of Canada

List of Companies Covered in this Report:

• Sun Life
• Manulife
• Canada Life
• Desjardins
• Medavie Blue Cross
• GreenShield
• Pacific Blue Cross
• Alberta Blue Cross
• Saskatchewan Blue Cross
• Blue Cross Canassurance (Quebec/ON)
• Beneva (SSQ/La Capitale)
• iA Financial Group (Industrial Alliance)
• Empire Life
• Equitable Life of Canada
• The Co-operators
• RBC Insurance (individual health)
• GroupHEALTH Benefit Solutions (TPA)
• Johnston Group (TPA)
• People Corporation (TPA/consulting)
• TELUS Health (PBM/eClaims)
• Express Scripts Canada (PBM)
• Blue Cross Life Insurance Company of Canada

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support